25 January 2019

VIVEbiotech participates in the Phacilitate Leaders World and World Stem Cell Summit 2019

VIVEbiotech participates in the Phaciliate Leaders World and World Stem Cell Summit 2019 that is taking place in Miami on January 22, 23, 24 and 25.

Read more

20 December 2018

Renewal of the registration of VIVEbiotech in the Register of Innovative SMEs

VIVEbiotech has been re-registered in the INNOVATIVE SME Registry of the General Directorate of Research, Development and Innovation of the Ministry of Science, Innovation and...

Read more

23 November 2018

VIVEbiotech receives the Technological Innovation SME Award granted by Expansión and Ifema

On November 19th the winners of the SME Awards granted by Expansión and Ifema were announced. VIVEbiotech won the Technological Innovation Award that was...

Read more

20 November 2018

Gurutz Linazasoro, CEO of VIVEbiotech, gave the lecture at the award ceremony of the XVIII. Manuel Laborde Werlinden Prize

The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, gave the lecture entitled "VIVEbioTECH, a story to tell" in the award ceremony of the XVIII. Manuel Laborde...

Read more

15 November 2018

Canal Europa interviews the CEO of VIVEbiotech, Dr. Gurutz Linazasoro

The CEO of VIVEbiotech, Dr. Gurutz Linazasoro, was interviewed by the Chief Scientific/Technology Officer of VIVEbiotech, Dr. Juan Carlos Ramírez, for Canal Europa.

Read more

9 November 2018

Successful participation of VIVEbiotech in BIO-Europe

BIO-Europe is the largest partnering conference in Europe focused on the biotechnology industry. The delegates of the different centers identify, participate and establish strategic relationships...

Read more

7 November 2018

José Manuel Franco, COO of VIVEbiotech, participates in a Roundtable on Ideas on how to transform knowledge into economic activity

The COO of VIVEbiotech, José Manuel Franco, participated in a Roundtable of Ideas that took place at CIC bioGUNE. José María Mato, the General...

Read more

2 November 2018

VIVEbiotech participates in the 26th annual congress of the ESGCT that took place in Lausanne

VIVEbiotech has participated in the 26th Congress of the European Society of Gene and Cell Therapy (ESGCT) that took place in Lausanne, Switzerland, on 16, 17, 18 and 19...

Read more

10 October 2018

The Chief Scientific/Technology Officer of VIVEbiotech, Juan Carlos Ramírez, participates in a symposium on gene therapy at the UAM

Dr. Juan Carlos Ramírez, Chief Scientific/Technology Officer of VIVEbiotech, participated in the informative symposium entitled "Present and Future Vision of Gene Therapy: 360º...

Read more

8 October 2018

VIVEbiotech signs three contracts for gene therapy clinical trials for 1.4 million euros

VIVEbiotech has signed three new contracts for the production of lentiviral vectors for three clinical trials for an amount of 1.4 million euros. Two of them...

Read more